Bitwise Asset Management has confirmed that its new spot exchange-traded fund (ETF) tracking XRP is set to launch on Thursday, under the ticker “XRP.” The new fund will go live on the New York Stock ...

Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...

The XRP exchange-traded fund boom is accelerating. “Today is the day! We’re launching the Bitwise XRP ETF,” said Bitwise on X. “It’s a big step forward for XRP, the world’s third-largest crypto asset, ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

This material must be accompanied by a prospectus. Please read the prospectus carefully before investing. To obtain a current prospectus visit bwowetf.com/welcome ...

XRP has fallen 5% this week as its ongoing decline continues despite growing institutional interest. The altcoin is struggling to recover, even with two XRP ETFs already live and two more scheduled to ...

Vanguard will now allow investors to trade crypto ETFs on its brokerage platform. The newly launched spot XRP ETF is up after Vanguard gave the green light to trade crypto ETFs on its platform, as ...

Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...

Fund provides exposure to the third-largest crypto asset, known for its 13-year track record and goal of disrupting the $250 trillion market for cross-border payments ...

Fund provides exposure to the third-largest crypto asset, known for its 13-year track record and goal of disrupting the $250 trillion market for cross-border payments. "In 2025, we're watching digital ...

A plea deal is in the works for the Fresno businessman accused of defrauding investors to loan millions of dollars to the failed Fresno-based startup company Bitwise Industries. David Hardcastle, 61, ...

Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...